AKT1 and systemic sclerosis: To confirm that, an impaired ubiquitination of VEGFR2 in SSc-MSCs, might modulate an increasing VEGF signaling, we investigated the PI3-kinase-Akt pathway, which has been reported to play a central role in VEGF activity[13].